Advancements in the treatment of pain: not all opioids are the same
Advancements in Health Research · 2024
DOI: 10.4081/ahr.2024.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advancements in Health Research, 2024. Verfasst von Robert B. Raffa. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
In the heated discourse about the pros and cons of opioids, it is not uncommon to have them discussed as if there are no significant differences among them (except perhaps on the basis of potency, viz., the piperidine fentanyl and its structural analogs such as alfentanil, carfentanil, sufentanil, etc.). It thus seems timely and appropriate to reassess this perception. There are at least three “atypical” opioids approved for clinical use, and another in development, that in one way or another display a more favorable clinical profile than do the “typical” opioids such as morphine, oxycodone, etc.
Zitieren
APA
Raffa, R. B. (2024). Advancements in the treatment of pain: not all opioids are the same. Advancements in Health Research. https://doi.org/10.4081/ahr.2024.3
Vancouver
Raffa RB. Advancements in the treatment of pain: not all opioids are the same. Advancements in Health Research. 2024. doi:10.4081/ahr.2024.3
BibTeX
@article{Raffa2024,
author = {Raffa, Robert B.},
title = {Advancements in the treatment of pain: not all opioids are the same},
journal = {Advancements in Health Research},
year = {2024},
doi = {10.4081/ahr.2024.3}
}
EUVIMED